Group 1 - ALK will publish its results for the first six months of 2025 on 21 August 2025, followed by a presentation for investors and analysts at 1:30 p.m. CEST [1] - The presentation will be available on ALK's website shortly before the meeting starts [4] - The meeting will be audio webcasted live and available for replay on ALK's website [2] Group 2 - Participants can join the conference call by registering through a provided link and will receive dial-in details via email [3] - ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma, employing around 2,800 people worldwide [6] - The company is headquartered in Hørsholm, Denmark, and is listed on Nasdaq Copenhagen [6]

Company Overview - AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics for various cancers, immune disorders, and viral diseases, including COVID-19 [3] - The company's lead product is Ampligen (rintatolimod), a first-in-class investigational drug that acts as a dsRNA and highly selective TLR3 agonist immuno-modulator with broad spectrum activity in clinical trials [3] Event Announcement - AIM ImmunoTech will present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech, which will be held virtually from August 19-21, 2025 [1] - The presentation is scheduled for August 20, 2025, at 2:40 PM ET, and will be led by Thomas Equels, the Chief Executive Officer, President & Executive Vice Chairman of the company [1]

Company Overview - Pandag Tech is an international smart equipment company focused on creating intelligent tools for commercial outdoor applications, emphasizing automation, sustainability, and user-centered design [6] Product Launch - The company will showcase its flagship product, the PANDAG-G1, at AgQuip 2025, marking its Australian debut [1] - The event will take place from August 19 to 21, 2025, at Booth I|16c [1] Product Features - The PANDAG-G1 operates autonomously on a single charge, capable of covering up to 15 acres of turf without supervision, allowing maintenance teams to focus on detailed tasks [2] - Designed for Australian conditions, the G1 can handle rugged terrain and climb slopes up to 78% [3] - It features an UltraSense™ navigation system that combines centimeter-level GPS accuracy with AI-powered obstacle detection for safe operation near roads and public areas [3] Versatility and Efficiency - The G1's modular design allows operators to switch between various functions such as mowing, trimming, spraying, and towing in seconds, reducing the need for multiple machines [4] - It is capable of heavy-duty vegetation control, cutting through overgrowth as tall as 4 feet, making it suitable for various applications including turf fields and large farms [5] Market Positioning - The PANDAG-G1 is positioned as a workhorse solution for maintaining large properties, focusing on safety, performance, and cost-efficiency [5]

Company Overview - BNB Network Company (Nasdaq: BNC) is the treasury management business of CEA Industries Inc, and it aims to build the world's largest corporate treasury of Binance Coin (BNB) [7] - The company has a clear ambition to become the benchmark institutional vehicle for BNB, focusing on a single-asset strategy [3] Recent Developments - BNC has recently purchased an additional 88,888 BNB tokens, reinforcing its position as the largest corporate holder of BNB tokens globally [1] - This acquisition follows an earlier purchase of 200,000 BNB tokens, moving the company closer to its goal of owning 1% of BNB's total supply by the end of 2025 [1] Market Position and Strategy - BNC's disciplined capital deployment and single-asset focus differentiate it from diversified digital asset treasuries, allowing it to capture BNB network effects and engage in on-chain yield strategies [3] - If the company's plans are fully executed, including potential warrants that could yield up to $750 million, BNC's BNB position could exceed $1.25 billion, establishing one of the largest digital asset treasuries in the world [4] Industry Context - BNB is the native token of BNB Chain, which is recognized as the number one blockchain by daily active addresses and decentralized trading volume, with over $12 billion in total value locked [2] - The BNB ecosystem is rapidly expanding, making it a core pillar of Web3 infrastructure [2]

Core Viewpoint - Jeffs' Brands Ltd is implementing an AI-driven crypto treasury management program to optimize yields from leading cryptocurrencies, including Bitcoin and stable coins [1][2]. Group 1: Treasury Program Overview - The Treasury Program will be managed by Quantum Crypto, an affiliate of Tectona Ltd, which holds a 41% stake in Horizon, a prominent Israeli crypto trading platform [1][3]. - The Company plans to allocate up to $75 million from a private placement of convertible promissory notes for the Treasury Program, contingent on the successful setup of crypto wallets [2]. Group 2: Agreement Details - An agreement was established on August 4, 2025, between Jeffs' Brands and Quantum Crypto for crypto treasury management services, including infrastructure and trading services [4]. - Jeffs' Brands will retain full ownership of its digital assets and private keys, with Quantum Crypto ensuring compliance with regulatory requirements [4]. Group 3: Compensation Structure - Quantum Crypto will receive a one-time setup fee of $25,000, a monthly fee of 0.125% of the average daily balance of managed crypto assets, and a performance-based fee of 20% of gross revenues from staking [5]. - The Company will also issue a warrant to Quantum Crypto for the purchase of up to 27,619 ordinary shares at an exercise price of $0.01 per share, representing approximately 4.99% of the currently outstanding shares [5]. Group 4: Company Background - Jeffs' Brands aims to transform e-commerce by creating and acquiring products to become market leaders, leveraging both human capability and advanced technology [6].

Social media following in brand portfolio increased from 5 million to 43 million in the 2nd quarter, which includes the previous announcements of new influencer brands during the current quarter.The current quarter 2025 revenues of $1.3 million, essentially flat compared with first quarter 2025, with minimal negative impacts to date from tariffs and current economic headwinds. Net loss on a GAAP basis was $4.0 million for the current quarter and $6.8 million on a year-to-date basis, inclusive of non-cash ch ...

Partnership expands MAX Amphibious ATV distribution and dealer network across key European markets BRADENTON, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Recreatives Industries, Inc. (OTC: RECX) (“Recreatives” or the “Company”), manufacturer of MAX Amphibious 6x6 All-Terrain Vehicles (www.maxatvs.com), today announced it has entered into a formal agreement with UK-based RICAN ATV, which has established RICAN Off-Road to serve as the exclusive importer and distributor for MAX vehicles, parts, and accessories acr ...

Second Quarter 2025 Net Loss of $1,290,000 ($0.39 loss per share) v. Net Loss of $201,000 ($0.06 loss per share) in Prior Year Comparable Period Second Quarter 2025 EBITDA, As Adjusted, was a loss of $1,049,000 ($0.32 loss per share) v. a loss of $405,000 ($0.12 loss per share) in Prior Year Comparable Period Six Months 2025 Net Loss of $3,442,000 ($1.03 loss per share) v. Net Loss of $952,000 ($0.28 loss per share) in Prior Year Comparable Period Six Months 2025 EBITDA, As Adjusted, was a loss of $2,998,00 ...

Positioning reflects exceptional year-over-year growth in vision, investments and industry impact Everest Group 2025 US IT Contingent Talent & Strategic Solutions PEAK Matrix® Kelly + Motion Recruitment has been selected as both an IT Leader and Star Performer on Everest Group’s 2025 US Contingent Staffing PEAK Matrix® Assessment. TROY, Mich., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Kelly + Motion Recruitment has been selected as both an IT Leader and Star Performer on Everest Group’s 2025 US Contingent Staffi ...

Following constructive FDA feedback on its proposed statistical analysis plan, Clene plans to analyze the neurofilament light data from its large NIH-sponsored Early Access Protocol early in the fourth quarter of 2025A second Type C meeting has been scheduled with the FDA in the third quarter of 2025 to review the survival benefit associated with CNM-Au8 dosingThe Company expects to submit a New Drug Application in the fourth quarter of 2025 for potential accelerated approval of CNM-Au8® in ALSA Type B end- ...